This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: David A England - Innovator in Cancer Treatment Formulations
Introduction
David A England is a notable inventor based in Northumberland, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for cancer treatment. His work focuses on enhancing the stability and efficacy of oxaliplatin solutions, which are crucial in combating cancer tumors.
Latest Patents
David A England holds 1 patent related to his innovative work. His patent, titled "Oxaliplatin formulations," pertains to pharmaceutically stable oxaliplatin solution formulations. This invention includes methods of use in the treatment of cancer tumors, processes for preparing such formulations, and techniques for stabilizing solutions of oxaliplatin.
Career Highlights
David is currently associated with Sanofi-Synthelabo, a leading pharmaceutical company. His role involves research and development aimed at improving cancer treatment options. His expertise in formulation chemistry has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues, including Martin R Gray and Nicholas H Anderson. These partnerships have fostered innovation and have contributed to advancements in cancer treatment formulations.
Conclusion
David A England's work in developing stable oxaliplatin formulations represents a significant advancement in cancer treatment. His contributions continue to impact the pharmaceutical field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile